<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=2101698893445396&amp;ev=PageView&amp;noscript=1">
Partners Advantage WebsiteFacebookLinkedInTwitterEmail
    Partners Advantage logo

    Ask the Actuary Your IUL Questions

    Posted by Steven Bieber on Mon, Feb 20, 2017 @ 05:24 PM

    Do you have questions about Indexed Universal Life Insurance? Are you interested in Orion IUL, the new product from Securian? Now there's an easy way to get answers to your questions through the "Ask the Actuary" live online events.


    Join the actuary that created the patent-pending Cash-Value Amplifier, which is prominently featured in Orion IUL. Jason Konopik is the Chief Financial Officer of AMZ Financial and has over 15 years experience in the life insurance industry. Jason relies on his actuarial, investment, and general insurance knowledge, in addition to his relationships with successful producers, to provide product development support to carriers AMZ represents. He has had a hand in the development of many of the most popular indexed life products sold in the last decade. In addition, he is an advocate of field education and has trained thousands of agents on the power of indexed products.

    Jason is hosting live online presentations on the following dates. If you have questions for Jason about Orion IUL that you'd like him to answer during the presentations, please leave them in the comments below.

    Upcoming Ask the Actuary Online Events

    Friday, February 24 - 11am-12pm CT - Registration Closed

    Wednesday, March 1 - 11am-12pm CT - Registration Closed

    Wednesday, March 8 - 11am-12pm CT - Registration Closed


    Please check back soon for more events.


    What is the most common concern your clients have about IUL?
    It's too expensive
    It's too complicated
    It's hard to access money
    Paramed exams and underwriting

    Tags: IUL (indexed universal life insurance), practice management


    This content is for informational and educational purposes only and is not designed, or intended, to be applicable to any person's individual circumstances. It should not be considered as investment advice, nor does it constitute a recommendation that anyone engage in (or refrain from) a particular course of action.

    Subscribe via E-mail